CD8A and neoplasm: In a previous study, we demonstrated that sustained release of αCD40 and αPD‐L1 mAbs via the NDES significantly reduced 4T1 murine TNBC tumor burden, induced CD8+ T cells tumor infiltration, and most importantly, avoided TRAE compared to systemic delivery.45